ValuEngine Downgrades Intuitive Surgical (ISRG) to Sell

Intuitive Surgical (NASDAQ:ISRG) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a report released on Friday.

A number of other brokerages also recently weighed in on ISRG. Wells Fargo & Co upped their price target on shares of Intuitive Surgical from $575.00 to $635.00 and gave the stock an “outperform” rating in a report on Wednesday, September 12th. Piper Jaffray Companies raised shares of Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 price target for the company in a report on Tuesday, October 9th. BidaskClub downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 22nd. Raymond James upped their price target on shares of Intuitive Surgical from $620.00 to $630.00 and gave the stock an “outperform” rating in a report on Friday, October 19th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $560.00 price target on shares of Intuitive Surgical in a report on Friday, October 19th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $556.01.

NASDAQ ISRG traded down $27.40 during trading on Friday, reaching $491.69. The company’s stock had a trading volume of 900,305 shares, compared to its average volume of 808,743. The company has a market capitalization of $59.25 billion, a P/E ratio of 68.39, a P/E/G ratio of 3.75 and a beta of 1.03. Intuitive Surgical has a 12 month low of $359.75 and a 12 month high of $581.12.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The company had revenue of $920.90 million during the quarter, compared to the consensus estimate of $916.22 million. During the same quarter in the prior year, the firm posted $2.77 EPS. The firm’s quarterly revenue was up 14.0% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical will post 9.52 earnings per share for the current fiscal year.

In related news, VP Jamie Samath sold 864 shares of the stock in a transaction that occurred on Tuesday, October 23rd. The shares were sold at an average price of $499.21, for a total value of $431,317.44. Following the completion of the transaction, the vice president now owns 257 shares of the company’s stock, valued at approximately $128,296.97. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Gary S. Guthart sold 28,085 shares of the stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $542.78, for a total transaction of $15,243,976.30. Following the completion of the transaction, the chief executive officer now directly owns 368,704 shares of the company’s stock, valued at approximately $200,125,157.12. The disclosure for this sale can be found here. In the last three months, insiders sold 72,491 shares of company stock valued at $37,767,784. 2.20% of the stock is owned by insiders.

Large investors have recently modified their holdings of the stock. CENTRAL TRUST Co lifted its stake in Intuitive Surgical by 26.4% in the 3rd quarter. CENTRAL TRUST Co now owns 460 shares of the medical equipment provider’s stock valued at $264,000 after purchasing an additional 96 shares during the last quarter. Crossmark Global Holdings Inc. lifted its stake in Intuitive Surgical by 25.7% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 14,564 shares of the medical equipment provider’s stock valued at $8,360,000 after purchasing an additional 2,977 shares during the last quarter. Carillon Tower Advisers Inc. increased its position in Intuitive Surgical by 3.7% in the 3rd quarter. Carillon Tower Advisers Inc. now owns 77,953 shares of the medical equipment provider’s stock valued at $44,745,000 after acquiring an additional 2,754 shares during the period. Signition LP acquired a new position in Intuitive Surgical in the 2nd quarter valued at approximately $240,000. Finally, United Capital Management of KS Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $205,000. 84.31% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Read More: Cost of Capital Explained

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply